Gunnar Gislason
Gunnar Gislason
Other namesGunnar Hilmar Gislason, Gunnar H Gislason, Gunnar Gislasson
Professor of Cardiology, Copenhagen University Hospital Herlev and Gentofte
Verified email at
Cited by
Cited by
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
JB Olesen, GYH Lip, ML Hansen, PR Hansen, JS Tolstrup, J Lindhardsen, ...
Bmj 342, 2011
Association of national initiatives to improve cardiac arrest management with rates of bystander intervention and patient survival after out-of-hospital cardiac arrest
M Wissenberg, FK Lippert, F Folke, P Weeke, CM Hansen, ...
Jama 310 (13), 1377-1384, 2013
Stroke and bleeding in atrial fibrillation with chronic kidney disease
JB Olesen, GYH Lip, AL Kamper, K Hommel, L Køber, DA Lane, ...
New England Journal of Medicine 367 (7), 625-635, 2012
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
ML Hansen, R Sørensen, MT Clausen, ML Fog-Petersen, J Raunsø, ...
Archives of internal medicine 170 (16), 1433-1441, 2010
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ...
The Lancet 391 (10117), 219-229, 2018
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective …
R Sørensen, ML Hansen, SZ Abildstrom, A Hvelplund, C Andersson, ...
The Lancet 374 (9706), 1967-1974, 2009
Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million …
TK Schramm, GH Gislason, L Køber, S Rasmussen, JN Rasmussen, ...
Circulation 117 (15), 1945-1954, 2008
Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial …
GH Gislason, S Jacobsen, JN Rasmussen, S Rasmussen, P Buch, ...
Circulation 113 (25), 2906-2913, 2006
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a ‘real world’nationwide cohort study
JB Olesen, GYH Lip, J Lindhardsen, DA Lane, O Ahlehoff, ML Hansen, ...
Thrombosis and haemostasis 106 (10), 739-749, 2011
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction …
TK Schramm, GH Gislason, A Vaag, JN Rasmussen, F Folke, ML Hansen, ...
European heart journal 32 (15), 1900-1908, 2011
Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention …
M Lamberts, JB Olesen, MH Ruwald, CM Hansen, D Karasoy, ...
Circulation 126 (10), 1185-1193, 2012
Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study
O Ahlehoff, GH Gislason, M Charlot, CH Jørgensen, J Lindhardsen, ...
Journal of internal medicine 270 (2), 147-157, 2011
The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study
J Lindhardsen, O Ahlehoff, GH Gislason, OR Madsen, JB Olesen, ...
Annals of the rheumatic diseases 70 (6), 929-934, 2011
Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a …
AM Schjerning Olsen, EL Fosbøl, J Lindhardsen, F Folke, M Charlot, ...
Circulation 123 (20), 2226-2235, 2011
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention
M Lamberts, GH Gislason, JB Olesen, SL Kristensen, ...
Journal of the American College of Cardiology 62 (11), 981-989, 2013
Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality
EL Fosbøl, JH Butt, L Østergaard, C Andersson, C Selmer, K Kragholm, ...
Jama 324 (2), 168-177, 2020
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ...
The Lancet 391 (10117), 205-218, 2018
Bystander efforts and 1-year outcomes in out-of-hospital cardiac arrest
K Kragholm, M Wissenberg, RN Mortensen, SM Hansen, C Malta Hansen, ...
New England Journal of Medicine 376 (18), 1737-1747, 2017
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction
GH Gislason, JN Rasmussen, SZ Abildstrøm, N Gadsbøll, P Buch, ...
European heart journal 27 (10), 1153-1158, 2006
Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure
GH Gislason, JN Rasmussen, SZ Abildstrom, TK Schramm, ML Hansen, ...
Archives of internal medicine 169 (2), 141-149, 2009
The system can't perform the operation now. Try again later.
Articles 1–20